Report on the application of high through-out technologies in lymphoma in the 54th ASH annual meeting / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 19-20, 2013.
Article
en Zh
| WPRIM
| ID: wpr-474666
Biblioteca responsable:
WPRO
ABSTRACT
Since the human gene code had been broken,the high through-out technologies based on genome-wide analysis have been well developed and extensively applied in cancers,which brought the innovation for the discovery of the pathogenesis and targeted drugs development of the cancer.After the successful application of these technologies in lymphomas,for example,gene expression profile in the diffuse large B cell lymphoma and next-generation sequencing technologies in hairy cell leukemia and Waldentr(o)m's macroglobulinemia,more and more researchers have tried to applied kinds of high through-out technologies in lymphomas,expecting to make improvements for the pathogenesis and prognosis of lymphomas.Many of the results had been reported in the 54th ASH annual meeting.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2013
Tipo del documento:
Article